Chapter/Section Purchase

1 Study Coverage
1.1 GABA Receptor Agonist Drug Product Introduction
1.2 Market by Type
1.2.1 Global GABA Receptor Agonist Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Bamaluzole
1.2.3 Phenibut
1.2.4 Baclofen
1.2.5 Gaboxadol
1.2.6 Klonopin (clonazepam)
1.2.7 Tiagbine
1.3 Market by Application
1.3.1 Global GABA Receptor Agonist Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Attention Deficit Hyperactivity Disorder (ADHD)
1.3.3 Psychiatric Disorders and Depression
1.3.4 Alzheimer
1.3.5 Epilepsy and Seizure
1.3.6 Anxiety and Sleep Disorders
1.3.7 Obesity and Alcoholism
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global GABA Receptor Agonist Drug Sales Estimates and Forecasts 2017-2028
2.2 Global GABA Receptor Agonist Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global GABA Receptor Agonist Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global GABA Receptor Agonist Drug Sales by Region
2.4.1 Global GABA Receptor Agonist Drug Sales by Region (2017-2022)
2.4.2 Global Sales GABA Receptor Agonist Drug by Region (2023-2028)
2.5 Global GABA Receptor Agonist Drug Revenue by Region
2.5.1 Global GABA Receptor Agonist Drug Revenue by Region (2017-2022)
2.5.2 Global GABA Receptor Agonist Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global GABA Receptor Agonist Drug Sales by Manufacturers
3.1.1 Global Top GABA Receptor Agonist Drug Manufacturers by Sales (2017-2022)
3.1.2 Global GABA Receptor Agonist Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of GABA Receptor Agonist Drug in 2021
3.2 Global GABA Receptor Agonist Drug Revenue by Manufacturers
3.2.1 Global GABA Receptor Agonist Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global GABA Receptor Agonist Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by GABA Receptor Agonist Drug Revenue in 2021
3.3 Global GABA Receptor Agonist Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global GABA Receptor Agonist Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global GABA Receptor Agonist Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global GABA Receptor Agonist Drug Sales by Type
4.1.1 Global GABA Receptor Agonist Drug Historical Sales by Type (2017-2022)
4.1.2 Global GABA Receptor Agonist Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global GABA Receptor Agonist Drug Sales Market Share by Type (2017-2028)
4.2 Global GABA Receptor Agonist Drug Revenue by Type
4.2.1 Global GABA Receptor Agonist Drug Historical Revenue by Type (2017-2022)
4.2.2 Global GABA Receptor Agonist Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global GABA Receptor Agonist Drug Revenue Market Share by Type (2017-2028)
4.3 Global GABA Receptor Agonist Drug Price by Type
4.3.1 Global GABA Receptor Agonist Drug Price by Type (2017-2022)
4.3.2 Global GABA Receptor Agonist Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global GABA Receptor Agonist Drug Sales by Application
5.1.1 Global GABA Receptor Agonist Drug Historical Sales by Application (2017-2022)
5.1.2 Global GABA Receptor Agonist Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global GABA Receptor Agonist Drug Sales Market Share by Application (2017-2028)
5.2 Global GABA Receptor Agonist Drug Revenue by Application
5.2.1 Global GABA Receptor Agonist Drug Historical Revenue by Application (2017-2022)
5.2.2 Global GABA Receptor Agonist Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global GABA Receptor Agonist Drug Revenue Market Share by Application (2017-2028)
5.3 Global GABA Receptor Agonist Drug Price by Application
5.3.1 Global GABA Receptor Agonist Drug Price by Application (2017-2022)
5.3.2 Global GABA Receptor Agonist Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America GABA Receptor Agonist Drug Market Size by Type
6.1.1 North America GABA Receptor Agonist Drug Sales by Type (2017-2028)
6.1.2 North America GABA Receptor Agonist Drug Revenue by Type (2017-2028)
6.2 North America GABA Receptor Agonist Drug Market Size by Application
6.2.1 North America GABA Receptor Agonist Drug Sales by Application (2017-2028)
6.2.2 North America GABA Receptor Agonist Drug Revenue by Application (2017-2028)
6.3 North America GABA Receptor Agonist Drug Market Size by Country
6.3.1 North America GABA Receptor Agonist Drug Sales by Country (2017-2028)
6.3.2 North America GABA Receptor Agonist Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe GABA Receptor Agonist Drug Market Size by Type
7.1.1 Europe GABA Receptor Agonist Drug Sales by Type (2017-2028)
7.1.2 Europe GABA Receptor Agonist Drug Revenue by Type (2017-2028)
7.2 Europe GABA Receptor Agonist Drug Market Size by Application
7.2.1 Europe GABA Receptor Agonist Drug Sales by Application (2017-2028)
7.2.2 Europe GABA Receptor Agonist Drug Revenue by Application (2017-2028)
7.3 Europe GABA Receptor Agonist Drug Market Size by Country
7.3.1 Europe GABA Receptor Agonist Drug Sales by Country (2017-2028)
7.3.2 Europe GABA Receptor Agonist Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific GABA Receptor Agonist Drug Market Size by Type
8.1.1 Asia Pacific GABA Receptor Agonist Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific GABA Receptor Agonist Drug Revenue by Type (2017-2028)
8.2 Asia Pacific GABA Receptor Agonist Drug Market Size by Application
8.2.1 Asia Pacific GABA Receptor Agonist Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific GABA Receptor Agonist Drug Revenue by Application (2017-2028)
8.3 Asia Pacific GABA Receptor Agonist Drug Market Size by Region
8.3.1 Asia Pacific GABA Receptor Agonist Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific GABA Receptor Agonist Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America GABA Receptor Agonist Drug Market Size by Type
9.1.1 Latin America GABA Receptor Agonist Drug Sales by Type (2017-2028)
9.1.2 Latin America GABA Receptor Agonist Drug Revenue by Type (2017-2028)
9.2 Latin America GABA Receptor Agonist Drug Market Size by Application
9.2.1 Latin America GABA Receptor Agonist Drug Sales by Application (2017-2028)
9.2.2 Latin America GABA Receptor Agonist Drug Revenue by Application (2017-2028)
9.3 Latin America GABA Receptor Agonist Drug Market Size by Country
9.3.1 Latin America GABA Receptor Agonist Drug Sales by Country (2017-2028)
9.3.2 Latin America GABA Receptor Agonist Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa GABA Receptor Agonist Drug Market Size by Type
10.1.1 Middle East and Africa GABA Receptor Agonist Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa GABA Receptor Agonist Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa GABA Receptor Agonist Drug Market Size by Application
10.2.1 Middle East and Africa GABA Receptor Agonist Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa GABA Receptor Agonist Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa GABA Receptor Agonist Drug Market Size by Country
10.3.1 Middle East and Africa GABA Receptor Agonist Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa GABA Receptor Agonist Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Advicenne
11.1.1 Advicenne Corporation Information
11.1.2 Advicenne Overview
11.1.3 Advicenne GABA Receptor Agonist Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Advicenne GABA Receptor Agonist Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Advicenne Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Corporation Information
11.2.2 AstraZeneca Overview
11.2.3 AstraZeneca GABA Receptor Agonist Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 AstraZeneca GABA Receptor Agonist Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AstraZeneca Recent Developments
11.3 Athena Drug Delivery Solutions
11.3.1 Athena Drug Delivery Solutions Corporation Information
11.3.2 Athena Drug Delivery Solutions Overview
11.3.3 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Athena Drug Delivery Solutions Recent Developments
11.4 Biocodex
11.4.1 Biocodex Corporation Information
11.4.2 Biocodex Overview
11.4.3 Biocodex GABA Receptor Agonist Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Biocodex GABA Receptor Agonist Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Biocodex Recent Developments
11.5 Elan Corporation
11.5.1 Elan Corporation Corporation Information
11.5.2 Elan Corporation Overview
11.5.3 Elan Corporation GABA Receptor Agonist Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Elan Corporation GABA Receptor Agonist Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Elan Corporation Recent Developments
11.6 Eli Lilly and Company
11.6.1 Eli Lilly and Company Corporation Information
11.6.2 Eli Lilly and Company Overview
11.6.3 Eli Lilly and Company GABA Receptor Agonist Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Eli Lilly and Company GABA Receptor Agonist Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Eli Lilly and Company Recent Developments
11.7 H.LundBeck, Merck and Co
11.7.1 H.LundBeck, Merck and Co Corporation Information
11.7.2 H.LundBeck, Merck and Co Overview
11.7.3 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 H.LundBeck, Merck and Co Recent Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Corporation Information
11.8.2 GlaxoSmithKline Overview
11.8.3 GlaxoSmithKline GABA Receptor Agonist Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 GlaxoSmithKline GABA Receptor Agonist Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 GlaxoSmithKline Recent Developments
11.9 NovaDel Pharma
11.9.1 NovaDel Pharma Corporation Information
11.9.2 NovaDel Pharma Overview
11.9.3 NovaDel Pharma GABA Receptor Agonist Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 NovaDel Pharma GABA Receptor Agonist Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 NovaDel Pharma Recent Developments
11.10 Novartis
11.10.1 Novartis Corporation Information
11.10.2 Novartis Overview
11.10.3 Novartis GABA Receptor Agonist Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Novartis GABA Receptor Agonist Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Novartis Recent Developments
11.11 OVATION Pharmaceuticals
11.11.1 OVATION Pharmaceuticals Corporation Information
11.11.2 OVATION Pharmaceuticals Overview
11.11.3 OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 OVATION Pharmaceuticals GABA Receptor Agonist Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 OVATION Pharmaceuticals Recent Developments
11.12 Osmotica Pharmaceutical
11.12.1 Osmotica Pharmaceutical Corporation Information
11.12.2 Osmotica Pharmaceutical Overview
11.12.3 Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Osmotica Pharmaceutical GABA Receptor Agonist Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Osmotica Pharmaceutical Recent Developments
11.13 Pfizer
11.13.1 Pfizer Corporation Information
11.13.2 Pfizer Overview
11.13.3 Pfizer GABA Receptor Agonist Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Pfizer GABA Receptor Agonist Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Pfizer Recent Developments
11.14 sanofi-aventis
11.14.1 sanofi-aventis Corporation Information
11.14.2 sanofi-aventis Overview
11.14.3 sanofi-aventis GABA Receptor Agonist Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 sanofi-aventis GABA Receptor Agonist Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 sanofi-aventis Recent Developments
11.15 VIVUS
11.15.1 VIVUS Corporation Information
11.15.2 VIVUS Overview
11.15.3 VIVUS GABA Receptor Agonist Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 VIVUS GABA Receptor Agonist Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 VIVUS Recent Developments
11.16 XenoPort
11.16.1 XenoPort Corporation Information
11.16.2 XenoPort Overview
11.16.3 XenoPort GABA Receptor Agonist Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 XenoPort GABA Receptor Agonist Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 XenoPort Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 GABA Receptor Agonist Drug Industry Chain Analysis
12.2 GABA Receptor Agonist Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 GABA Receptor Agonist Drug Production Mode & Process
12.4 GABA Receptor Agonist Drug Sales and Marketing
12.4.1 GABA Receptor Agonist Drug Sales Channels
12.4.2 GABA Receptor Agonist Drug Distributors
12.5 GABA Receptor Agonist Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 GABA Receptor Agonist Drug Industry Trends
13.2 GABA Receptor Agonist Drug Market Drivers
13.3 GABA Receptor Agonist Drug Market Challenges
13.4 GABA Receptor Agonist Drug Market Restraints
14 Key Findings in The Global GABA Receptor Agonist Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer